Skip to main content
Top
Literature
1.
go back to reference Gopalan V, Smith RA, Ho YH, et al. Signet-ring cell carcinoma of colorectum-current perspectives and molecular biology. Int J Color Dis. 2011;26:127–33.CrossRef Gopalan V, Smith RA, Ho YH, et al. Signet-ring cell carcinoma of colorectum-current perspectives and molecular biology. Int J Color Dis. 2011;26:127–33.CrossRef
2.
go back to reference Makino T, Tsujinaka T, Mishima H, et al. Primary signet-ring cell carcinoma of the colon and rectum: report of eight cases and review of 154 Japanese cases. Hepatogastroenterology. 2006;53:845–9.PubMed Makino T, Tsujinaka T, Mishima H, et al. Primary signet-ring cell carcinoma of the colon and rectum: report of eight cases and review of 154 Japanese cases. Hepatogastroenterology. 2006;53:845–9.PubMed
Metadata
Title
Signet Ring Cell Carcinoma of Both Colon and Pancreas
Authors
Fatih Karaahmet
Omer Basar
Sahin Coban
Gulden Aydoğ
Osman Yuksel
Publication date
01-12-2015
Publisher
Springer US
Published in
Journal of Gastrointestinal Cancer / Issue 4/2015
Print ISSN: 1941-6628
Electronic ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-015-9763-7

Other articles of this Issue 4/2015

Journal of Gastrointestinal Cancer 4/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine